ArticleCancer reports (Hoboken, N.J.)2025

Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.

Taichi Hirano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.